Navigation Links
Amgen to Present at the Barclays Capital Global Healthcare Conference
Date:3/9/2009

THOUSAND OAKS, Calif., March 9 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) will present at the Barclays Capital Global Healthcare Conference on Wednesday, March 11, 2009 at the Loews Miami Beach Hotel, Miami Beach, Fla., beginning at 9:00 a.m. Eastern Time. Amgen's Chief Financial Officer Robert A. Bradway will present. Live audio of the presentation will be available over the Internet and can be accessed from Amgen's Web site, www.amgen.com, under Investors.

Information regarding presentation time, webcast availability, and webcast links are available on Amgen's Investor Relations Events Calendar.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

    CONTACT: Amgen, Thousand Oaks
    David Polk, 805-447-4613 (media)
    Justin Claeys, 805-447-1060 (investors)

(Logo: http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO)


'/>"/>
SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1

Related medicine news :

1. OmniPod(R) Insulin Management System Lets Team Type 1 Members Focus on Competing at Amgen Tour of California
2. InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer
3. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
4. Masimo to Present at the Cowen and Company 29th Annual Healthcare Conference
5. ProteoTech to Present at 9th International Conference for Alzheimers and Parkinsons Disease - Prague, Czech Republic, March 11-15, 2009
6. Brookdale to Present at Barclays Capital Global Healthcare Conference March 11
7. Destination Fashion 2009 Presented by Stewart Rahr -
8. West to Present at the 2009 Barclays Global Healthcare Conference
9. Beckman Coulter to Present at Upcoming Healthcare Conferences
10. Savient Pharmaceuticals to Present at The Cowen and Company 29th Annual Healthcare Conference on March 17, 2009
11. Covance to Present at the Barclays Capital Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... NEW YORK (May 22, 2012) -- Up to half of ... in a new "fusion" gene and formation of its unique ... promotes cancer growth. Now, Weill Cornell Medical College researchers have ... DNA, wrapped up in a little ball known as a ... has been thrown on thousands of genes, turning them on ...
(Date:5/22/2012)... to stray from her breeding partner and mate with ... that sleeping around can be costly. , The 20-year ... found that offspring conceived outside sparrows, social pairs ... offspring. The findings throw a monkey wrench into theories ... cheat. , Most bird species display some form of ...
(Date:5/22/2012)... Environmental Health Sciences (NIEHS), part of the National Institutes ... Program (SRP) at the University of California, San Diego. ... will fund continued research on the molecular and genetic ... other hazardous waste sites. , It is the third ... originally funded by the NIEHS in 2000. , ...
(Date:5/22/2012)... HealthDay Reporter , , MONDAY, May 21 (HealthDay News) ... unleash heated debate, a prominent U.S. government advisory ... no longer be screened for prostate cancer by ... The U.S. Preventive Services Task Force, an independent ... medicine, said PSA screening results in overdiagnosis of ...
(Date:5/22/2012)... TUESDAY, May 22 (HealthDay News) -- Hundreds of ... virus could develop potentially life-threatening liver complications over ... study. Researchers evaluated medical insurance claims data ... patients had advanced liver disease in 2008, and ... liver disease by 2015. The risk of ...
Breaking Medicine News(10 mins):Health News:Scientists unravel role of fusion gene in prostate cancer 2Health News:Scientists unravel role of fusion gene in prostate cancer 3Health News:Scientists unravel role of fusion gene in prostate cancer 4Health News:For monogamous sparrows, it doesn't pay to stray (but they do it anyway) 2Health News:UC San Diego Superfund Research Program receives $15 million grant renewal 2Health News:U.S. Advisers Say 'No' to Routine PSA Tests for Prostate Cancer 2Health News:U.S. Advisers Say 'No' to Routine PSA Tests for Prostate Cancer 3Health News:Hepatitis C Causing Liver Damage in Greater Numbers: Study 2
... in the wee small hours Friday with an all-night music ... onto the streets , while New York swung along for ... vibe changed from area to area. Thousands flocked to Abbesses ... streets as small-time artists enjoyed their 15 minutes of fame, ...
... importance as scientists believe it plays a key role in ... fevers diseases that infect over 50 million people ... of the Aedes aegypti mosquito which transmits deadly viral diseases ... the first of its kind on the newly-sequenced genome of ...
... Governments measures to address Indigenous child abuse, initially in the ... the AMA to play the key role in addressing this ... that the AMA is seeking a briefing from the Prime ... the proposals so work can commence as soon as practicable. ...
... said that all villages affected by chikungunya fever would ... awareness among people even as 17,000 suspected cases ... year. ,'We have asked the nine chikungunya-affected states ... Rural Health Mission, we will provide Rs.10,000 each to ...
... found that, apart from being heavy, overweight children share something ... 40 overweight children in Edmonton has revealed that each one ... found in intestinal cholesterol. ,The children presented high ... are characteristically high in overweight adults, remained in the normal ...
... Leire Garca Navarro, a researcher at the School of Pharmacy ... suffering colon and liver cancer. The new treatment has ... ,This discovery is the principal result of her ... in Cancer Cells of the Colon, which was subsidized by ...
Other Medicine News:Health News:France Celebrates Summer With All-night Music Fest; NY Swings Along 2Health News:Aedes Agypti Mosquitos Immune System Revealed 2Health News:Indigenous Child Abuse 2Health News:Chikungunya-hit Villages to Get Funds to Fight Mosquitoes 2Health News:Researchers Identify New Risk Marker for Obese Children 2Health News:Novel Treatment Beneficial for Colon and Liver Cancer 2
(Date:5/22/2012)... 22, 2012  Unigene Laboratories, Inc. (OTCBB: ... manufacture and development of peptide-based therapeutics today reported ... rats and dogs for its lead proprietary anorexigenic ... anorexigenic peptide selectively targeting the amylin receptor, is ... morbid obesity.  In multiple-dose pharmacology studies in rats ...
(Date:5/22/2012)... 22, 2012  Systech International, a leading provider ... protect product integrity and authenticity, today announced that ... Vice President. Mr. Harty will be ... of Systech,s Cloud Products and Solutions, and aligning ... "Mr. Harty has a unique perspective of ...
(Date:5/22/2012)... and BELGRADE, Serbia, May 22, 2012 ... for cardiovascular and renal diseases, presented positive data ...  In the study of 111 heart failure patients ... heart failure symptoms as compared to placebo.    ... 2a study were presented in an oral session ...
Breaking Medicine Technology:Unigene's Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies 2Unigene's Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies 3Unigene's Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies 4Unigene's Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies 5David F. Harty Joins Systech International as Vice President 2Sorbent Therapeutics' CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study 2Sorbent Therapeutics' CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study 3Hendrick Construction Completes Oak Ridge National Laboratory Expansion 16182 1Hendrick Construction Completes Oak Ridge National Laboratory Expansion 16182 2Reportlinker Adds The World Anesthesia Drug Market 8758 1Reportlinker Adds The World Anesthesia Drug Market 8758 2Reportlinker Adds The World Anesthesia Drug Market 8758 3Reportlinker Adds The World Anesthesia Drug Market 8758 4Reportlinker Adds The World Anesthesia Drug Market 8758 5Reportlinker Adds The World Anesthesia Drug Market 8758 6Reportlinker Adds The World Anesthesia Drug Market 8758 7Reportlinker Adds The World Anesthesia Drug Market 8758 8Reportlinker Adds The World Anesthesia Drug Market 8758 9Reportlinker Adds The World Anesthesia Drug Market 8758 10Rice team talks the walk 71623 1Rice team talks the walk 71623 2Rice team talks the walk 71623 3
... May 15 Creighton Medical Laboratories, based at ... today that it has become the first clinical laboratory ... method for cancer. The method, called SNP array karyotyping, ... study cancer for several years. However, Creighton Medical Laboratories, ...
... Be PresentedFRANKLIN, Mass., May 15 PLC Systems ... on innovative cardiac and vascular medical device-based technologies, ... System(TM) at EuroPCR, the annual meeting of the ... 19-22, 2009, in Barcelona, Spain. More than ...
Other Medicine Technology:Creighton Medical Laboratories First to Offer New Cancer Test 2Creighton Medical Laboratories First to Offer New Cancer Test 3PLC Medical Systems to Demonstrate RenalGuard(R) at EuroPCR 2009 2PLC Medical Systems to Demonstrate RenalGuard(R) at EuroPCR 2009 3PLC Medical Systems to Demonstrate RenalGuard(R) at EuroPCR 2009 4
... generation tissue valve from Medtronic, is the ... The Mosaic valve builds upon three decades ... excellent choice for patients who require aortic ... valve. For more than 20 years, Medtronics ...
Medtronic Aortic Punches are intended for use by cardiac surgeons during coronary artery bypass grafting procedures to create an opening in the wall of the vessel. All punches are sterile and disposa...
... treat heart rhythms that are abnormally fast ... often are used to treat sudden cardiac ... reduce the SCD mortality rate for these ... to less than 2 percent as verified ...
... new HF35-50 High Frequency Ultrasound system is ... high frequency system available. The HF35-50 allows ... of the anterior segment with 35MHz or ... ultrasound with a 20 MHz sealed B-probe. ...
Medicine Products: